-
FDA Grants Fast Track to Sanofi’s Chlamydia mRNA Vaccine
Mar 27 2025 -
Alcon Acquires Majority Stake in Cell Therapy Startup Aurion
Mar 27 2025 -
Epicrispr Biotechnologies Announces $68M Series B to Advance First-in-Class FSHD Epigenetic Therapy to Clinic
Mar 26 2025 -
Turn Bio Acquires Vesigen’s Drug Delivery Tech to Expand mRNA Therapy Reach
Mar 25 2025 -
SineuGene’s SNUG01: First TRIM72 Gene Therapy for ALS Enters Clinical Trials
Mar 24 2025 -
Verve Therapeutics Expands Gene Editing Trial for Cholesterol Treatment to the U.S.
Mar 24 2025 -
Regenxbio Presents Positive Duchenne Gene Therapy Data
Mar 21 2025 -
Optieum Biotechnologies Receives $39M AMED Grant for CAR-T Development
Mar 21 2025 -
Sickle Cell Patient Achieves Remission with Gene Therapy
Mar 21 2025